Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/21706316

Download in:

View as

General Info

PMID
21706316